| Net loss | -13.05M |
| Depreciation and amortization | 7.63K |
| Stock-based compensation | 403.21K |
| Accounts receivable | |
| Prepaid expenses and other assets | 312.16K |
| Accounts payable | 445.54K |
| Accrued expenses and compensation | 5.12M |
| Unearned revenues | |
| Net cash used in operating activities | -6.6M |
| Net cash provided by investing activities | 0 |
| Payments on capital lease obligations | |
| Payment of withholding taxes related to restricted stock units | 0 |
| Proceeds from sale of common stock units and warrant and exercise | |
| Net cash provided by (used in) financing activities | 7.46M |
| NET DECREASE IN CASH AND CASH EQUIVALENTS | 865.26K |
| CASH AND CASH EQUIVALENTS, beginning of period | 8M |
| CASH AND CASH EQUIVALENTS, end of period | 8.87M |
| Cash paid for interest | 457.8K |
| Unrealized gain on available-for-sale investments | |